Zichen Zhao
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Clinical outcomes for neoadjuvant immunochemotherapy or chemotherapy versus concurrent chemoradiotherapy in limited-stage small-cell lung cancer: A retrospective, multi-center, real-world study.
Journal: International journal of cancer
Published: May 20, 2025
Collateral lethality: A unique type of synthetic lethality in cancers.
Journal: Pharmacology & therapeutics
Published: August 10, 2024
Synergistic effect of canakinumab with epidermal growth factor receptor tyrosine kinase inhibitors versus with chemotherapy for non-small cell lung cancer.
Journal: Translational lung cancer research
Published: March 20, 2024
Determination of Pralsetinib in Human Plasma and Cerebrospinal Fluid for Therapeutic Drug Monitoring by Ultra-performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS).
Journal: Anti-cancer agents in medicinal chemistry
Published: January 03, 2024
Rhabdomyolysis in a patient with advanced lung cancer treated with osimertinib: a case report.
Journal: Translational lung cancer research
Published: December 26, 2022
Response to Pralsetinib Observed in Meningeal-Metastatic EGFR-Mutant NSCLC With Acquired RET Fusion: A Brief Report.
Journal: JTO clinical and research reports
Published: April 08, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026